Suppr超能文献

乳腺癌放射治疗中使用的器官保留技术和剂量体积限制——欧洲和拉丁美洲调查结果

Organ-sparing techniques and dose-volume constrains used in breast cancer radiation therapy - Results from European and Latin American surveys.

作者信息

Chirilă Monica-Emila, Kraja Fatjona, Marta Gustavo Nader, Neves Junior Wellington Furtado Pimenta, de Arruda Gustavo Viani, Gouveia André Guimarães, Franco Pierfrancesco, Poortmans Philip, Ratosa Ivica

机构信息

Radiation Oncology Department, Amethyst Radiotherapy Centre, Cluj-Napoca, Romania.

Department of Clinical Development, MVision AI, Helsinki, Finland.

出版信息

Clin Transl Radiat Oncol. 2024 Feb 19;46:100752. doi: 10.1016/j.ctro.2024.100752. eCollection 2024 May.

Abstract

BACKGROUND

Advances in local and systemic therapies have improved the outcomes of patients with breast cancer (BC), leading to a possible increased risk for postoperative radiation therapy (RT) late adverse events. The most adequate technologies and dose constraints for organs at risk (OAR) in BC RT have yet to be defined.

METHODS

An online survey was distributed to radiation oncologists (ROs) practicing in Europe and Latin America including the Caribbean (LAC) through personal contacts, RO and BC professional groups' networks. Demographic data and clinical practice information were collected.

RESULTS

The study included 585 responses from ROs practicing in 57 different countries. The most frequently contoured OAR by European and LAC participants were the whole heart (96.6 % and 97.7 %), the ipsilateral (84.3 % and 90.8 %), and contralateral lung (71.3 % and 77.4 %), whole lung (69.8 % and 72.9 %), and the contralateral breast (66.4 % and. 83.2 %). ESTRO guidelines were preferred in Europe (33.3 %) and the RTOG contouring guideline was the most popular in LAC (62.2 %), while some participants used both recommendations (13.2 % and 19.2 %). IMRT (68.6 % and 59.1 %) and VMAT (65.6 % and 60.2 %) were the preferred modalities used in heart sparing strategies, followed by deep inspiration breath-hold (DIBH) (54.8 % and 37.4 %) and partial breast irradiation (PBI) (41.6 % and 24.6 %). Only a small percentage of all ROs reported the dose-volume constraints for OAR used in routine clinical practice. A mean heart dose (Heart-D) between 4 and 5 Gy was the most frequently reported parameter (17.2 % and 39.3 %).

CONCLUSION

The delineation approaches and sparing techniques for OAR in BC RT vary between ROs worldwide. The low response rate to the dose constraints subset of queries reflects the uncertainty surrounding this topic and supports the need for detailed consensus recommendations in the clinical practice.

摘要

背景

局部和全身治疗方法的进展改善了乳腺癌(BC)患者的治疗效果,这可能导致术后放射治疗(RT)晚期不良事件的风险增加。BC放疗中针对危及器官(OAR)的最适当技术和剂量限制尚未确定。

方法

通过个人联系、放疗肿瘤学家(RO)和BC专业团体网络,向在欧洲、拉丁美洲包括加勒比地区(LAC)执业的放疗肿瘤学家发放在线调查问卷。收集人口统计学数据和临床实践信息。

结果

该研究纳入了来自57个不同国家的RO的585份回复。欧洲和LAC参与者最常勾画的OAR是全心(分别为96.6%和97.7%)、同侧(分别为84.3%和90.8%)和对侧肺(分别为71.3%和77.4%)、全肺(分别为69.8%和72.9%)以及对侧乳腺(分别为66.4%和83.2%)。欧洲人更倾向于ESTRO指南(33.3%),而RTOG勾画指南在LAC最受欢迎(62.2%),同时一些参与者同时使用这两种推荐(分别为13.2%和19.2%)。调强放疗(IMRT)(分别为68.6%和59.1%)和容积旋转调强放疗(VMAT)(分别为65.6%和60.2%)是心脏保护策略中首选的方式,其次是深吸气屏气(DIBH)(分别为54.8%和37.4%)和部分乳腺照射(PBI)(分别为41.6%和24.6%)。所有RO中只有一小部分报告了常规临床实践中使用的OAR剂量体积限制。4至5 Gy之间的平均心脏剂量(心脏剂量)是最常报告的参数(分别为17.2%和39.3%)。

结论

全球范围内的放疗肿瘤学家在BC放疗中对OAR的勾画方法和保护技术各不相同。对剂量限制问题子集的低回复率反映了围绕该主题的不确定性,并支持在临床实践中需要详细的共识性建议。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验